1832 Asset Management L.P. Neurocrine Biosciences Inc Transaction History

1832 Asset Management L.P.

$55.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $66 Million - $72.2 Million	504,400 Added 1370.65%	541,200 $74.5 Million
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $547,680 - $603,708	-4,200 Reduced 10.24%	36,800 $5.08 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $4.35 Million - $5.44 Million	41,000 New	41,000 $5.4 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $23.1 Million - $27.5 Million	216,500 Added 45.59%	691,400 $82.6 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $36.6 Million - $42.9 Million	397,500 Added 513.57%	474,900 $50.4 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $5.87 Million - $7.75 Million	77,400 New	77,400 $7.55 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $19.8 Million - $27.8 Million	-205,600 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $29.8 Million - $45.7 Million	-350,700 Reduced 63.04%	205,600 $25.5 Million
Q1 2020 May 26, 2020	BUY	$75.11 - $113.76 $41.8 Million - $63.3 Million	556,300 New	556,300 $49.9 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $47.9 Million - $72.6 Million	-637,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $9.36 Million - $12.8 Million	107,800 Added 20.34%	637,900 $67.3 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $44.4 Million - $53.8 Million	530,100 New	530,100 $46.8 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $45 Million - $81.9 Million	-658,700 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $26.8 Million - $34.1 Million	271,300 Added 70.03%	658,700 $79.2 Million
Q2 2018 Aug 14, 2018	BUY	$75.3 - $105.99 $29.2 Million - $41.1 Million	387,400 New	387,400 $37 Million
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $4.83 Million - $5.89 Million	-63,700 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $3.73 Million - $4.94 Million	63,700	63,700 $4.92 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

Black Rock Inc. New York, NY

14.2M
Shares

$1.78 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

4.61M
Shares

$578 Million
0.03% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$323 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.9M
Shares

$238 Million
4.37% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Account